← Eichor
Study identifier: NCT05640453 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Pregabalin Versus Dexmedetomidine for Delirium Treatment After Coronary Artery Bypass Grafting

Condition: Pregabalin · Delirium Treatment · Coronary Artery Bypass Grafting  ·  Sponsor: Tanta University

PhasePhase 4
Planned participants70
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

The aim of this study is to determine the effect of pregabalin versus dexmedetomidine on the treatment and lasting duration of delirium in fast tracking elderly patients after Coronary Artery Bypass Grafting.

This description comes directly from the study's public registry record.

Talk to the study team

Islam Morsy, MD  ·  00201093387374  ·  eslam.morsy@med.tanta.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Islam MorsyTanta, El-Gharbia Governorate, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05640453